The short version of dual agonist fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-02. Anything still debated is marked as such rather than presented as settled.
Purified material is typically handled as a lyophilized powder kept at or below minus twenty degrees Celsius, shielded from light and moisture. In that state the solid remains stable for extended periods, although repeated freeze-thaw cycling can encourage aggregation. Once dissolved, aqueous solutions are less durable and are generally held cold and used within a brief window. Buffer composition, pH and ionic strength all influence degradation rates, and mildly acidic to neutral conditions are commonly examined. Actual shelf life depends on formulation, concentration and container, so stability limits are established experimentally rather than assumed.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual inspection serves only as a preliminary check |
| Solubility | Freely soluble in water and aqueous buffers | Gentle mixing may be needed to reach full dissolution |
| Typical storage | Minus 20 degrees Celsius or colder, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Primary analytical method | Reversed-phase HPLC with mass detection | Purity reported as chromatographic area percent |
| Common synonyms | GIP/GLP-1 dual agonist; LY3298176 | Development codes are distinct from approved product names |
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Oveporexton, sold under the brand name Orzeyful, is a medication used for the treatment of narcolepsy type 1. It is taken by mouth. The most common side effects include insomnia, increased urinary frequency, urgency to urinate, and increased saliva production. Oveporexton is an orexin OX2 receptor agonist. Oveporexton was approved for medical use in China in July 2026, and in the United States in August 2026. It is recommended for scheduling under the Controlled Substances Act and will be lawful to market in the US following the scheduling decision issued by the Drug Enforcement Administration.
Halim, Adilla Nur; Abdul Rani, Aidatul Azura; et al. (Kadri, Rozeeda; Abdul Aziz, Farhana; Ridzuan, Mohd Naufal; Hassan, Ali Noor; Wazir, Maznah; Arzeni, Lydiawati) (2017). Amalan Perubatan Tradisional Melayu bagi Penjagaan Ibu-Ibu Selepas Bersalin di Negeri Kelantan [Traditional Malay Medical Practices for Postpartum Maternal Care in Kelantan] (PDF) (in Malay). Traditional and Complementary Medicine Practice Branch, Traditional and Complementary Medicine Division, Ministry of Health of Malaysia. pp. 1–90. ISBN 978-983-44782-9-2. Archived (PDF) from the original on 2 June 2025. Mazliadiyana, M; Nazrun, AS; Isa, NM (2017). "Optimum Dose of Sea Cucumber (Stichopus Chloronotus) Extract for Wound Healing" (PDF). Med & Health. 12 (1): 83–89. doi:10.17576/MH.2017.1201.09. Devi Oktaviani, Paramita; Wahjuningsih, Endah; Andriani, Dwi (2018). "Efektivitas Suplementasi Teripang Emas (Stichopus Hermanii) Dalam Mencegah Terjadinya Oral Candidiasis Pada Tikus Wistar" [Effectivity of Stichopus hermanii Supplementation to Prevent Oral Candidiasis on Rats]. Denta (Jurnal Kedokteran Gigi) (in Indonesian). 12 (1): 9–15. doi:10.30649/denta.v12i1.155. ISSN 1907-5987. Archived from the original on 1 June 2025. Text is licensed by DENTA (Journal Kedokteran Gigi) under CC BY-NC-SA 4.0 Hafiz Leong, Muhamad Nur; Mohd Fauzi, Noor Akhmazillah; Rahim Kamarudin, Kamarul; Mohamed Rehan, Aisyah (2021). "Investigation of Bioactive Compounds from Sea Cucumber Extract and Stingless Bee Honey Using Critical Literature Review and Bioinformatics Approach for Potential Synergy Combination".
Stable nuclei, and unstable nuclei with very long half-lives, follow a trend of stability evident when Z is plotted against N. For lighter nuclei less than N = 20, the line has the slope N = Z, while the heavier nuclei require additional neutrons to remain stable. Nuclei that are neutron- or proton-rich have excessive binding energy for stability, and the excess energy may convert a neutron to a proton or a proton to a neutron via the weak nuclear force, a process known as beta decay. Neutron-induced fission of U-235 emits a total energy of 207 MeV, of which about 200 MeV is recoverable, Prompt fission fragments amount to 168 MeV, which are easily stopped with a fraction of a millimeter. Prompt neutrons total 5 MeV, and this energy is recovered as heat via scattering in the reactor. However, many fission fragments are neutron-rich and decay via β− emissions. According to Lilley, "The radioactive decay energy from the fission chains is the second release of energy due to fission. It is much less than the prompt energy, but it is a significant amount and is why reactors must continue to be cooled after they have been shut down and why the waste products must be handled with great care and stored safely."
Sources: en.wikipedia.org
=== Kurdistan === Hitchens was a longtime observer of Saddam Hussein's regime, and publicly called for his removal, albeit only beginning in 1998. This led him to support the establishment of a self-governing state for the Kurds with political autonomy, if not full independence.
Skeptics Report investigation of Therapeutic Touch Archived 2009-12-15 at the Wayback Machine Therapeutic Touch at the Skeptic's Dictionary Dunning, Brian (April 27, 2010). "Skeptoid #203: Therapeutic Touch". Skeptoid.
After the Rollercoaster Tour to support the album, the band concentrated on cracking the United States' market, with an appearance on David Letterman's show, and a tour as part of the Lollapalooza line-up, which William later described as "the worst experience of our lives," followed by their own headlining tour. In December 1992, the Reids again lost their rhythm section, with Ben Lurie returning and Steve Monti joining on drums. Another compilation was released in 1993, The Sound of Speed, before they returned to the studio to record their fifth album proper, Stoned & Dethroned which would see release in 1994, and featured guest appearances from Shane MacGowan and William's then-girlfriend Hope Sandoval. The album was originally planned as an acoustic album, but this idea was abandoned because, in Jim's words, "We couldn't do enough interesting things with acoustic guitars to make an album". In the 1995 EP released under American Records, a number of new works and B-sides were published which were later collected in the album Munki. After the release of the 1995 compilation Hate Rock 'N' Roll, the Mary Chain parted ways with Blanco y Negro, their record label of over a decade, and re-signed to their original label Creation Records, and Sub Pop in America. The band now included former Lush bassist Phil King. They then recorded 1998's Munki album, which would turn out to be their last before splitting the following year. Munki was commercially the least successful album the band released, peaking at number forty-seven in the UK Album Chart.
== History == Tofu making was first recorded during the Chinese Han dynasty. Chinese legend ascribes its invention to Prince Liu An (179–122 BC) of Anhui province. Tofu and its production technique were introduced to Japan during the Nara period (710–794) but there are no clear records; tofu first appeared on record in AD 965. Some scholars believe tofu arrived in Vietnam during the 10th and 11th centuries. It spread to other parts of Southeast Asia as well. This probably coincided with the spread of Buddhism as it is an important source of protein in the vegetarian diet of East Asian Buddhism. Li Shizhen, during the Ming dynasty, described a method of making tofu in the Compendium of Materia Medica. Since then, tofu has become a staple in many countries, including Vietnam, Thailand, and Korea, with regional variations in production methods, texture, flavor, and usage.
Sources: en.wikipedia.org
Liquid chromatography combined with mass spectrometry is the most common approach. Digestion followed by peptide mapping verifies the sequence and modification sites. Results are judged against a reference standard or a theoretically calculated mass.
Lower temperatures slow most degradation routes, and storage at minus twenty degrees Celsius or below is standard for lyophilized material. Repeated warming and cooling imposes stress on the molecule. Dissolved samples deteriorate faster and are usually handled over shorter periods.
It normally reflects the relative chromatographic area of the principal peak. It does not capture every possible impurity or demonstrate biological function. Additional methods are required to describe a sample completely.
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.